GLENMARK PHARMACEUTICALS
|
The Current P/S Ratio of GLENMARK PHARMACEUTICALS is 4.26.
Share Price | ₹2,014.4 | Sep 22,2025 |
Market Cap | ₹56,845.0 Cr | |
Sales-TTM | ₹13,342.0 Cr | TTM-Consolidated Results |
Price/Sales | 4.26x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GLENMARK PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹56,845.0 Cr] as on Sep 22,2025
(/) Sales [ ₹13,342.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.26x ]
Thus, for GLENMARK PHARMACEUTICALS , the investors are currently willing to pay '4.26 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GLENMARK PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of GLENMARK PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of GLENMARK PHARMACEUTICALS
PS Ratio Performance Analysis for GLENMARK PHARMACEUTICALS
- GLENMARK PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.78x.
- GLENMARK PHARMACEUTICALS 's operated at median p/e ratio of 1.2x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GLENMARK PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 3.26x.
- GLENMARK PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2022 of 1.01x.
How does GLENMARK PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GLENMARK PHARMACEUTICALS | 13,342.0 | 4.26 | 56,845.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.33 | 394,451.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.76 | 161,727.0 |
CIPLA LTD | 27,811.2 | 4.48 | 124,533.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.45 | 123,673.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.24 | 108,629.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.27 | 107,160.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.41 | 104,190.0 |
LUPIN LTD | 23,375.9 | 3.92 | 91,599.8 |
AUROBINDO PHARMA LTD | 32,024.8 | 2.03 | 64,910.4 |
ABBOTT INDIA LTD | 6,589.9 | 9.74 | 64,191.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLENMARK PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.03x |
Max industry PS | 16.76x |
Median industry PS | 4.48x |
Average industry PS | 6.81x |
You may also like the below Video Courses